scholarly journals Cost Effectiveness Analysis of A Flash Glucose Monitoring System for Type 1 Diabetes (T1DM) Patients Receiving Intensive Insulin Treatment in Europe and Australia

2016 ◽  
Vol 19 (7) ◽  
pp. A697-A698 ◽  
Author(s):  
SP Bilir ◽  
H Li ◽  
EA Wehler ◽  
R Hellmund ◽  
J Munakata
Keyword(s):  
Type 1 Diabetes ◽  
Cost Effectiveness ◽  
Monitoring System ◽  
Insulin Treatment ◽  
Glucose Monitoring ◽  
Flash Glucose Monitoring ◽  
Intensive Insulin Treatment ◽  
Effectiveness Analysis ◽  
Flash Glucose Monitoring System

scholarly journals Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden

2018 ◽  
Vol 14 (2) ◽  
pp. 73 ◽  
Author(s):  
S Pinar Bilir ◽  
Richard Hellmund ◽  
Beth Wehler ◽  
Huimin Li ◽  
Julie Munakata ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Cost Effectiveness ◽  
Insulin Treatment ◽  
Glucose Monitoring ◽  
Base Case ◽  
Flash Glucose Monitoring ◽  
Intensive Insulin Treatment ◽  
Scenario Analyses ◽  
The Impact

Flash glucose monitoring – an alternative to traditional self-monitoring of blood glucose (SMBG) – prevents hypoglycaemic events without impacting glycated haemoglobin (HbA1c).21Given the potential benefits, this study assessed the cost-effectiveness of using flash monitoring versus SMBG alone in patients with type 1 diabetes (T1D) receiving intensive insulin treatment in Sweden.Methods:This study used the IQVIA CORE Diabetes Model (IQVIA CDM, v9.0) to simulate the impact of flash monitoring versus SMBG over 50 years from the Swedish societal perspective. Trial data informed cohort data, intervention effects, and resource utilisation; literature and Tandvårds-Läkemedelförmånsverket (TLV) sources informed utilities and costs. Scenario analyses explored the effect of key base case assumptions.Results:In base case analysis, direct medical costs for flash monitor use were SEK1,222,333 versus SEK989,051 for SMBG use. Flash monitoring led to 0.80 additional quality-adjusted life years (QALYs; 13.26 versus 12.46 SMBG) for an incremental cost effectiveness ratio (ICER) of SEK291,130/QALY. ICERs for all scenarios remained under SEK400,000/QALY.Conclusion:Hypoglycaemia and health utility benefits due to flash glucose monitoring may translate into economic value compared to SMBG. With robust results across scenario analyses, flash monitoring may be considered cost-effective in a Swedish population of T1D intensive insulin users.

2368-PUB: Cost Analysis of a Flash Glucose Monitoring System in Type 1 Diabetes Vulnerable Patients, in Spain

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 2368-PUB
Author(s):  
FERNANDO GOMEZ-PERALTA ◽  
ITZIAR OYAGÜEZ ◽  
JUAN F. MERINO-TORRES ◽  
MIGUEL BRITO ◽  
FRANCISCO M. MORALES-PEREZ ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Cost Analysis ◽  
Monitoring System ◽  
Glucose Monitoring ◽  
Flash Glucose Monitoring ◽  
Vulnerable Patients ◽  
Flash Glucose Monitoring System
Sign in / Sign up

Export Citation Format

Share Document